Capital Fund Management (CFM)’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-116,183	Closed	-$2.29M	–	2483
2025 Q3	$2.29M	Buy	116,183 +36,112	+45%	+$743K	0.02%	1720
2025 Q2	$1.74M	Buy	80,071 +7,737	+11%	+$183K	0.02%	1750
2025 Q1	$1.75M	Sell	72,334 -51,122	-41%	-$1.15M	0.02%	1471
2024 Q4	$2.58M	Sell	123,456 -9,123	-7%	-$196K	0.03%	1386
2024 Q3	$2.64M	Buy	132,579 +6,492	+5%	+$120K	0.03%	1306
2024 Q2	$1.95M	Sell	126,087 -131,448	-51%	-$2.05M	0.02%	1395
2024 Q1	$4.11M	Buy	257,535 +6,316	+3%	+$95.2K	0.05%	1142
2023 Q4	$4.22M	Sell	251,219 -117,250	-32%	-$1.6M	0.05%	1169
2023 Q3	$4.31M	Buy	368,469 +44,063	+14%	+$589K	0.06%	1011
2023 Q2	$4.36M	Buy	324,406 +12,656	+4%	+$182K	0.07%	899
2023 Q1	$5.17M	Buy	311,750 +197,016	+172%	+$3.25M	0.1%	726
2022 Q4	$2.13M	Buy	114,734 +87,576	+322%	+$1.35M	0.05%	914
2022 Q3	$348K	Sell	27,158 -33,668	-55%	-$399K	0.01%	1334
2022 Q2	$426K	Buy	+60,826	New	+$446K	0.01%	1278
2020 Q4	–	Sell	-144,063	Closed	-$428K	–	1362
2020 Q3	$428K	Buy	144,063 +23,793	+20%	+$93K	0.01%	1074
2020 Q2	$556K	Buy	+120,270	New	+$540K	0.02%	860
2020 Q1	–	Sell	-24,725	Closed	-$93K	–	1651
2019 Q4	$93K	Buy	+24,725	New	+$116K	﹤0.01%	1781